Market Research Logo

Glaukos Corporation (GKOS) - Product Pipeline Analysis, 2016 Update

Summary

Glaukos Corporation (Glaukos) is an ophthalmic medical device company that research and develops micro technologies to improve glaucoma therapy. The company’s products include microstent devices to treat glaucoma such as iStent trabecular micro-bypass stent for the treatment of mild- tomoderate open-angle glaucoma. Its iStent is used in conjunction with cataract surgery. Glauko’s iStent improves outflow by creating a patent bypass between the anterior chamber and Schlemm’s canal. It markets its products through a network of distributors in Germany, Italy, Canada, Portugal, Spain, the UK and France. Glaukos is headquartered in Laguna Hills, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Glaukos Corporation
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


Glaukos Corporation Company Snapshot
Glaukos Corporation Company Overview
Glaukos Corporation Pipeline Products and Clinical Trials Overview
Glaukos Corporation – Pipeline Analysis Overview
Key Facts
Glaukos Corporation - Major Products and Services
Glaukos Corporation Pipeline Products by Development Stage
Glaukos Corporation Clinical Trials by Trial Status
Glaukos Corporation Pipeline Products Overview
GTS400
GTS400 Product Overview
iDose Travoprost Intraocular Implant
iDose Travoprost Intraocular Implant Product Overview
iDose Travoprost Intraocular Implant Clinical Trial
iStent Inject - Cataract Surgery
iStent Inject - Cataract Surgery Product Overview
iStent Inject - Cataract Surgery Clinical Trial
iStent Inject - Standalone Procedures
iStent Inject - Standalone Procedures Product Overview
iStent Supra
iStent Supra Product Overview
iStent Supra Clinical Trial
iStent Trabecular Micro-Bypass Stent
iStent Trabecular Micro-Bypass Stent Product Overview
iStent Trabecular Micro-Bypass Stent Clinical Trial
Glaukos Corporation - Key Competitors
Glaukos Corporation - Key Employees
Glaukos Corporation - Locations And Subsidiaries
Head Office
Recent Developments
Glaukos Corporation, Recent Developments
May 03, 2016: Glaukos Announces First Quarter 2016 Financial Results
Apr 28, 2016: Glaukos Technologies Featured In Numerous Presentations At 2016 American Society Of Cataract And Refractive Surgery
Apr 14, 2016: Glaukos Announces Retirement Of Olav Bergheim From Board Of Directors
Mar 28, 2016: Glaukos iStent Trabecular Micro-Bypass Stent Approved in Japan
Mar 01, 2016: Glaukos Announces Fourth Quarter & Full Year 2015 Financial Results
Feb 08, 2016: Glaukos Establishes Direct Sales Organization and Launches iStent inject Trabecular Micro-Bypass Stent in Australia
Feb 01, 2016: Glaukos Launches New Direct Sales Organization and Begins Commercialization of iStent inject Trabecular Micro-Bypass Stent in Canada
Jan 20, 2016: International Study Shows 3-Year Benefits of Glaukos iStent Trabecular Micro-Bypass Stent in Combination with Cataract Surgery
Jan 12, 2016: Glaukos Provides Preliminary Fourth Quarter and Full Year 2015 Net Sales and Full Year 2016 Net Sales Guidance
Jan 07, 2016: Glaukos Will Begin Phase II Clinical Trial For Idose Travoprost Intraocular Implant In Glaucoma Patients
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Glaukos Corporation Pipeline Products and Clinical Trials Overview
Glaukos Corporation Pipeline Products by Equipment Type
Glaukos Corporation Pipeline Products by Indication
Glaukos Corporation Clinical Trials by Trial Status
Glaukos Corporation, Key Facts
Glaukos Corporation, Major Products and Services
Glaukos Corporation Number of Pipeline Products by Development Stage
Glaukos Corporation Pipeline Products Summary by Development Stage
Glaukos Corporation Clinical Trials by Trial Status
Glaukos Corporation Clinical Trials Summary
GTS400 - Product Status
GTS400 - Product Description
iDose Travoprost Intraocular Implant - Product Status
iDose Travoprost Intraocular Implant - Product Description
iDose Travoprost Intraocular Implant - Assessment of iDose Delivery System's Safety and Preliminary Efficacy for the Reduction of Elevated Intraocular Pressure
iStent Inject - Cataract Surgery - Product Status
iStent Inject - Cataract Surgery - Product Description
iStent Inject - Cataract Surgery - A Prospective, Randomized Evaluation of Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost Ophthalmic Solution 0.004%
iStent Inject - Cataract Surgery - A Prospective, Randomized, Single-masked, Controlled, Parallel Groups, Multicenter Clinical Investigation of the Glaukos Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction with Cataract Surgery
iStent Inject - Standalone Procedures - Product Status
iStent Inject - Standalone Procedures - Product Description
iStent Supra - Product Status
iStent Supra - Product Description
iStent Supra - A Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medication Treated with One Suprachoroidal Stent
iStent Supra - A Prospective Evaluation of Open-angle Glaucoma Subjects with One Prior Trabeculectomy Treated Concurrently with One Suprachoroidal Stent and Two Trabecular Micro-bypass Stents and a Postoperative Prostaglandin
iStent Trabecular Micro-Bypass Stent - Product Status
iStent Trabecular Micro-Bypass Stent - Product Description
iStent Trabecular Micro-Bypass Stent - A Prospective Evaluation of Open-angle Glaucoma Subjects on One Topical Hypotensive Medication Randomized to Treatment with One or Two Trabecular Micro-bypass Stents in Conjunction with Cataract Surgery
iStent Trabecular Micro-Bypass Stent - A Prospective Evaluation of Open-angle Glaucoma Subjects on One Topical Hypotensive Medication Treated with Two Trabecular Micro-bypass Stents
iStent Trabecular Micro-Bypass Stent - A Prospective Evaluation of Open-angle Glaucoma Subjects with One Prior Trabeculectomy Treated Concurrently with One Suprachoroidal Stent and Two Trabecular Micro-bypass Stents and a Postoperative Prostaglandin
iStent Trabecular Micro-Bypass Stent - A Prospective, Multicenter, Randomized Comparison of the Hydrus Microstent to the iStent for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
iStent Trabecular Micro-Bypass Stent - A Prospective, Multicenter, Randomized Comparison of the Hydrus to the iStent for Lowering Intraocular Pressure in Primary Open Angle Glaucoma
iStent Trabecular Micro-Bypass Stent - A Prospective, Randomized Evaluation of Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost Ophthalmic Solution 0.004%
iStent Trabecular Micro-Bypass Stent - A Prospective, Randomized Evaluation of Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated with Two Trabecular Micro-bypass Stents (iStent) or Travoprost Ophthalmic Solution 0.004%
iStent Trabecular Micro-Bypass Stent - A Prospective, Randomized, Controlled Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medications, Implanted with One, Two, or Three Trabecular Micro-bypass Stents
iStent Trabecular Micro-Bypass Stent - A Prospective, Randomized, Controlled Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medications, Implanted with One, Two, Or Three Trabecular Micro-bypass Stents
iStent Trabecular Micro-Bypass Stent - A Prospective, Randomized, Controlled, Parallel Groups Evaluation of Open-angle Glaucoma Subjects on One Ocular Hypotensive Medication Randomized to Treatment with Two Trabecular Micro-bypass Stents or Selective Laser Trabeculoplasty
iStent Trabecular Micro-Bypass Stent - A Prospective, Randomized, Controlled, Parallel Groups, Multi-center Post-Approval Study Of The Glaukos iStent Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery
iStent Trabecular Micro-Bypass Stent - A Prospective, Randomized, Single-Masked, Controlled, Parallel Groups, Multi-center Clinical Investigation of the Glaukos Suprachoroidal Stent Model G3 In Conjunction with Cataract Surgery
iStent Trabecular Micro-Bypass Stent - A Prospective, Randomized, Single-masked, Controlled, Parallel Groups, Multicenter Clinical Investigation of the Glaukos Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction with Cataract Surgery
iStent Trabecular Micro-Bypass Stent - Glaukos iStent Trabecular Micro-Bypass Stent System In Conjunction with Cataract Surgery Postmarket Registry
iStent Trabecular Micro-Bypass Stent - International Study of iStent in Phakic and Pseudophakic Glaucoma Patients
iStent Trabecular Micro-Bypass Stent - Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser Trabeculoplasty
Glaukos Corporation, Key Employees
List of Figures
Glaukos Corporation Pipeline Products by Equipment Type
Glaukos Corporation Pipeline Products by Development Stage
Glaukos Corporation Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report